BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9643129)

  • 1. [Clinically significant drug interactions in HIV-infected patients].
    Weisser M; Battegay M
    Ther Umsch; 1998 May; 55(5):310-22. PubMed ID: 9643129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Emergencies in HIV infection].
    Burckhardt B; Battegay M
    Ther Umsch; 1998 May; 55(5):295-301. PubMed ID: 9643127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease inhibitor plasma concentrations in HIV antiretroviral therapy.
    Justesen US
    Dan Med Bull; 2008 Nov; 55(4):165-85. PubMed ID: 19232158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions among drugs for HIV and opportunistic infections.
    Piscitelli SC; Gallicano KD
    N Engl J Med; 2001 Mar; 344(13):984-96. PubMed ID: 11274626
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential drug interacations.
    Posit Aware; 1996; 7(2):14-5. PubMed ID: 11363359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interactions with drugs used in the treatment of HIV and infective complications peculiar to HIV infected patients.
    Griffin JP
    Adverse Drug React Toxicol Rev; 2000 Mar; 19(1):47-88. PubMed ID: 10826280
    [No Abstract]   [Full Text] [Related]  

  • 9. Double jeopardy: the hazards of drug-drug interactions.
    Flexner C
    Res Initiat Treat Action; 1998 Dec; 4(7):3-8. PubMed ID: 11366084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of late-presenting patients with HIV infection.
    Rockstroh JK; Gatell J; Landman R; Antinori A
    Antivir Ther; 2010; 15 Suppl 1():25-30. PubMed ID: 20442458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring and human immunodeficiency virus (HIV) antiretroviral therapy.
    Justesen US
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):20-31. PubMed ID: 16433887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of antiretroviral agents.
    Bean P; Patnaik M; Graziano FM; Aziz DC
    Am Clin Lab; 2000 May; 19(4):20-2. PubMed ID: 10947316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Mar; 49(9):185-9. PubMed ID: 11795500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically relevant drug interactions with antiretroviral agents.
    Burger DM; Hoetelmans RM; Koopmans PP; Meenhorst PL; Mulder JW; Hekster YA; Beijnen JH
    Antivir Ther; 1997 Jul; 2(3):149-65. PubMed ID: 11322270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection and advanced age emerging epidemiological, clinical, and management issues.
    Manfredi R
    Ageing Res Rev; 2004 Jan; 3(1):31-54. PubMed ID: 15164725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic hepatitis C in HIV-infected patients. Unfavorable interaction of HIV and HCV infection].
    Mauss S
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():60-2. PubMed ID: 10863316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of clinical pharmacology in the monitoring of therapy of HIV-infected subjects].
    Villani P; Cocchi L; Giacchino R; Seminari E; Regazzi MB; Maserati R
    Clin Ter; 1996 Jun; 147(6):279-93. PubMed ID: 8925637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.